⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27783941 | 0.98 | — | — | |
| SCHEMBL24467767 | 0.68 | — | — | |
| SCHEMBL10919953 | 0.68 | — | — | |
| SCHEMBL1664032 | 0.65 | HTR6 (0.32) | — | |
| SCHEMBL25038692 | 0.65 | BRD4 (0.36) | — | |
| SCHEMBL27817134 | 0.64 | HTR6 (0.31) | — | |
| SCHEMBL30483496 | 0.61 | HTR2A (0.34) | — | |
| SCHEMBL28839808 | 0.61 | HTR2A (0.34) | — | |
| SCHEMBL11541427 | 0.60 | HTR6 (0.37) | — | |
| SCHEMBL647672 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2221296-B1 | FUSED INDANE COMPOUND | ASTELLAS PHARMA INC (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-8211907-B2 | Fused indane compound | ASTELLAS PHARMA INC. (JP) | 2012-07-03 | — | — | US | disclosed |
| US-20100267695-A1 | FUSED INDANE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2221296-A1 | FUSED INDANE COMPOUND | Astellas Pharma Inc. (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-4537892-A | ANTIDIABETIC AGENTS | ALCON LABORATORIES, INC. (US) | 1985-08-27 | — | — | US | disclosed |